Sperogenix Therapeutics, a platform company dedicated to developing and commercializing rare disease therapeutics in China, and Minoryx Therapeutics, a company that specializes in the development of i...
Other participants in Connecta’s capital increase included CDTI, through the Innvierte program for innovative Spanish technology companies; the founders of Prous Institute for Biomedical Research, J...
The financing was led by Soleus Capital and co-led by Eir Ventures. Several new investors joined the round: Cormorant Asset Management, Janus Henderson Investors, Hadean Ventures, Sphera, Asymmetry Ca...
Aortyx ha sido la startup más votada en la final de los Premis Àlex Casta como mejor pitch de la Bioregión. La startup fundada y dirigida por Jordi Martorell (ver la entrevista que le hicimos) ha o...
With three months until the end of 2020, the life sciences and healthcare sector in Catalonia is flexing its muscles, in spite of expectations it would be a challenging year due to the Covid-19 pandem...
Medlumics, which develops Ablaview®, a unique RF irrigated ablation catheter system that merges photonics and miniaturized optics to guide device placement and directly assess the ablation lesions in...
Según José Manuel de Bartolomé, socio del Fondo SOPEF “Symborg cumple todos los requisitos que se buscan en las inversiones de capital riesgo, se trata de un proyecto de crecimiento y expansión,...
The company aptaTargets has closed the second round of financing, with the participation of Inveready and the CDTI, through its INNVIERTE program, which will allow it to mobilize up to 5 million euros...
La ronda de serie B ha sido liderada por los fondos internacionales Charme Capital Partners y Amadeus Capital Partners, que ya se encontraban en el accionariado desde la fundación de la start up en 2...
A lo largo de su extensa trayectoria empresarial, el CDTI ha apoyado a grupo Zendal en numerosos proyectos de I+D, aportando la inversión necesaria para poder alcanzar no solo la excelencia científi...
SparingVision, a genomic medicine company focused on ocular diseases, today announces a €44.5 million financing round. The round was led by 4BIO Capital and UPMC Enterprises, and included Jeito Capi...
Seed Capital Bizkaia, a través del Fondo I, participa en este innovador proyecto. El Fondo I es una de las herramientas de financiación que ofrece Seed Capital Bizkaia para el apoyo de iniciativas e...